<?xml version="1.0" encoding="UTF-8"?>
<p>At the end of December 2019, local health officials in the Chinese city of Wuhan, Hubei province reported a cluster of 27 cases of ‘pneumonia of unknown cause’. The clinical symptoms of cases included fever, headache, difficulty breathing and pneumonia, with lung invasive lesions on chest radiography (Wang, Horby, Hayden, &amp; Gao, 
 <xref rid="tbed13509-bib-0005" ref-type="ref">2020</xref>). In an initial case series of patients admitted to hospital in Wuhan, 6 of 41 (15%) died (Huang et al., 
 <xref rid="tbed13509-bib-0002" ref-type="ref">2020</xref>). Reported cases were epidemiologically linked to a wholesale seafood and animal market in the city. In January, the first death was reported, and the aetiology was identified as a new coronavirus, ‘2019‐nCoV’ (also called ‘Wuhan coronavirus’). It has been retrospectively concluded that there was evidence of human‐to‐human transmission as early as mid‐December (Li et al., 
 <xref rid="tbed13509-bib-0004" ref-type="ref">2020</xref>), and based on modelling studies, it has been estimated that 75,815 individuals (95% credible interval 37,304–130,330) had already been infected in Wuhan as of 25 January (Wu, Leung, &amp; Leung, 
 <xref rid="tbed13509-bib-0006" ref-type="ref">2020</xref>).
</p>
